The glucose metabolism disorder and dyslipidemia among girls with different phenotype polycystic ovary syndrome

被引:10
作者
Akbarzadeh, Marzieh [1 ]
Naderi, Tahereh [2 ]
Dabbaghmanesh, Mohammad H. [3 ]
机构
[1] Shiraz Univ Med Sci, Maternal Fetal Med Res Ctr, Sch Nursing & Midwifery, Dept Midwifery, Shiraz, Iran
[2] Shiraz Univ Med Sci, Community Based Psychiat Care Res Ctr, Sch Nursing & Midwifery, Dept Midwifery, Shiraz, Iran
[3] Shiraz Univ Med Sci, Dept Internal Med, Endocrine & Metab Res Ctr, Shiraz, Iran
来源
JOURNAL OF RESEARCH IN MEDICAL SCIENCES | 2019年 / 24卷
关键词
Metabolic syndrome; phenotype; polycystic ovarian syndrome; CARDIOVASCULAR-DISEASE; RISK-FACTORS; PREVALENCE; ADOLESCENTS; DIAGNOSIS; CHILDREN;
D O I
10.4103/jrms.JRMS_804_16
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study aimed to determine the prevalence of glucose metabolism disorder and dyslipidemia in 14-18-year-old girls with different phenotype polycystic ovary syndrome (PCOS). Materials and Methods: This descriptive, cross-sectional study was conducted on 3200 high-school adolescents aged 14-18 years in Shiraz in 2010. Selected parameters of metabolic syndrome (fasting blood glucose, glucose tolerance test [GTT], insulin level, triglyceride (TG), cholesterol, and high-density lipoprotein [HDL]), based on adult treatment panel. definition criteria, were compared between the "PCOS" and control groups. Results: Results were compared at four main phenotypes. The level of serum TG was increased in the Phenotype B (P = 0.03) and Phenotype D (P = 0.01), compared to the control group. Cholesterol and low-density lipoprotein levels (P < 0.05) and GTT (P > 0.05) were increased, and HDL was decreased (was below 50) in all the four phenotypes and the control group (P > 0.05). Conclusion: The risk of metabolic alterations of glucose metabolism disorder and dyslipidemia in PCOS adolescents was more than non-PCOS counterparts.
引用
收藏
页数:5
相关论文
共 26 条
  • [1] Incidence and Trend of a Metabolic Syndrome Phenotype Among Tehranian Adolescents Findings from the Tehran Lipid and Glucose Study, 1998-2001 to 2003-2006
    Afkhami-Ardekani, Mohammad
    Zahedi-Asl, Saleh
    Rashidi, Maryam
    Atifah, Mitra
    Hosseinpanah, Farhad
    Azizi, Fereidoun
    [J]. DIABETES CARE, 2010, 33 (09) : 2110 - 2112
  • [2] A survey of metabolic syndrome in first-degree relatives (fathers) of patients with polycystic ovarian syndrome
    Akbarzadeh, M.
    Moradi, F.
    Dabbaghmanesh, M. H.
    Jafari, P.
    Parsanezhad, M. E.
    [J]. JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2013, 18 (02) : 98 - 103
  • [3] Akbarzadeh M, 2013, ASIAN J DERMATOL, V5, P11
  • [4] Akbarzadeh M, 2015, INT J AFR NURS SCI, V3, P82, DOI DOI 10.1016/J.IJANS.2015.09.001
  • [5] American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5
  • [6] Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men
    Arnlov, Johan
    Ingelsson, Erik
    Sundstrom, Johan
    Lind, Lars
    [J]. CIRCULATION, 2010, 121 (02) : 230 - U88
  • [7] Metabolic syndrome as a risk factor for diabetes
    Aschner, Pablo
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (03) : 407 - 412
  • [8] Baillargeon Jean-Patrice, 2005, Curr Opin Investig Drugs, V6, P1012
  • [9] Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults
    Berenson, GS
    Srinivasan, SR
    Bao, WH
    Newman, WP
    Tracy, RE
    Wattigney, WA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (23) : 1650 - 1656
  • [10] Prevalence of metabolic syndrome in a Portuguese obese adolescent population according to three different definitions
    Braga-Tavares, Hugo
    Fonseca, Helena
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2010, 169 (08) : 935 - 940